Ohio Public Employees Retirement System (OPERS)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.26M Sell
103,730
-571
-0.5% -$29.5K 0.02% 567
2026
Q1
$5.3M Sell
104,301
-3,554
-3% -$166K 0.02% 653
2025
Q4
$3.18M Sell
107,855
-2,957
-3% -$80.3K 0.01% 895
2025
Q3
$2.86M Buy
110,812
+687
+0.6% +$19.2K 0.01% 936
2025
Q2
$3.04M Sell
110,125
-22,775
-17% -$600K 0.01% 884
2025
Q1
$3.77M Sell
132,900
-4,398
-3% -$156K 0.01% 772
2024
Q4
$5.71M Sell
137,298
-6,797
-5% -$325K 0.02% 653
2024
Q3
$9.63M Sell
144,095
-1,172
-0.8% -$108K 0.04% 414
2024
Q2
$17.3M Sell
145,267
-11,062
-7% -$1.4M 0.07% 248
2024
Q1
$16.7M Sell
156,329
-11,421
-7% -$1.15M 0.07% 269
2023
Q4
$16.7M Buy
167,750
+624
+0.4% +$52.5K 0.07% 265
2023
Q3
$17.3M Sell
167,126
-15,386
-8% -$1.72M 0.08% 239
2023
Q2
$22.2M Sell
182,512
-9,733
-5% -$1.3M 0.09% 203
2023
Q1
$29.5M Sell
192,245
-5,909
-3% -$975K 0.12% 157
2022
Q4
$35.6M Sell
198,154
-2,442
-1% -$399K 0.15% 127
2022
Q3
$23.7M Sell
200,596
-2,156
-1% -$327K 0.11% 179
2022
Q2
$29M Buy
202,752
+2,429
+1% +$347K 0.12% 163
2022
Q1
$34.5M Sell
200,323
-6,921
-3% -$1.17M 0.12% 162
2021
Q4
$52.6M Sell
207,244
-6,465
-3% -$1.89M 0.18% 105
2021
Q3
$82.2M Sell
213,709
-764
-0.4% -$282K 0.29% 62
2021
Q2
$50.4M Buy
214,473
+60,876
+40% +$10.9M 0.18% 115
2021
Q1
$20.1M Buy
153,597
+11,637
+8% +$1.69M 0.08% 221
2020
Q4
$14.8M Buy
141,960
+26,603
+23% +$2.69M 0.07% 263
2020
Q3
$8.16M Buy
115,357
+12,866
+13% +$897K 0.04% 345
2020
Q2
$6.58M Buy
102,491
+16,812
+20% +$921K 0.04% 431
2020
Q1
$2.57M Buy
85,679
+15,861
+23% +$365K 0.02% 727
2019
Q4
$1.37M Sell
69,818
-2,069
-3% -$36.7K 0.01% 1068
2019
Q3
$1.14M Buy
71,887
+63,706
+779% +$941K 0.01% 1140
2019
Q2
$120K Sell
8,181
-305
-4% -$6.55K ﹤0.01% 1593
2019
Q1
$173K Buy
+8,486
New +$158K ﹤0.01% 1533

Other funds holding MRNA

Ohio Public Employees Retirement System (OPERS)'s MRNA Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) reduced its Moderna (MRNA) stake by 0.55% in Q2 2026, selling an estimated $29.5K and leaving 103,730 shares worth $7.26M. The position accounts for 0.02% of the portfolio, ranked #567.

Ohio Public Employees Retirement System (OPERS) first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $82.2M in Q3 2021. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) held 103,730 shares of Moderna worth $7.26M as of Q2 2026.
  • Ohio Public Employees Retirement System (OPERS) sold 571 Moderna shares in Q2 2026, an estimated $29.5K.
  • Moderna made up 0.02% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q2 2026, its #567 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
  • Ohio Public Employees Retirement System (OPERS)'s Moderna position peaked at $82.2M in Q3 2021.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.